Andra L Wilkinson1, Carolyn Tucker Halpern2, Amy H Herring3, Meghan Shanahan4, Susan T Ennett5, Jon M Hussey2, Kathleen Mullan Harris6. 1. Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: wilkina@live.unc.edu. 2. Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 3. Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 4. Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Injury Prevention Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 5. Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 6. Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Sociology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Abstract
PURPOSE: Both substance use and depression are common in adolescence and often comorbid. Past research has produced conflicting results on whether there is a temporal relationship, and if so, in which direction it operates and how it may vary by sex. We examined the longitudinal associations between substance use frequency and depressive symptoms from adolescence into young adulthood and whether the associations were moderated by sex. METHODS: With data from Waves I, III, and IV of the National Longitudinal Study of Adolescent to Adult Health (n = 9,816), we used growth curve models to test if depressive symptoms predicted marijuana use or binge drinking frequency (Self-Medication Model) or if substance use frequency predicted depressive symptoms (Stress Model). Moderation by sex and age was tested for both potential pathways. RESULTS: Increases in adolescent depressive symptoms, compared to no symptoms, were associated with a steeper predicted increase in marijuana use frequency from adolescence to young adulthood. Increases in persistent binge drinking or marijuana use frequency had concurrent positive associations with depressive symptoms from adolescence to young adulthood, and these associations were significantly stronger for females compared to males. CONCLUSIONS: The results not only support the Self-Medication Model for marijuana use but also provide modest support for the Stress Model, that substance use is associated with depressive symptoms, especially for females.
PURPOSE: Both substance use and depression are common in adolescence and often comorbid. Past research has produced conflicting results on whether there is a temporal relationship, and if so, in which direction it operates and how it may vary by sex. We examined the longitudinal associations between substance use frequency and depressive symptoms from adolescence into young adulthood and whether the associations were moderated by sex. METHODS: With data from Waves I, III, and IV of the National Longitudinal Study of Adolescent to Adult Health (n = 9,816), we used growth curve models to test if depressive symptoms predicted marijuana use or binge drinking frequency (Self-Medication Model) or if substance use frequency predicted depressive symptoms (Stress Model). Moderation by sex and age was tested for both potential pathways. RESULTS: Increases in adolescent depressive symptoms, compared to no symptoms, were associated with a steeper predicted increase in marijuana use frequency from adolescence to young adulthood. Increases in persistent binge drinking or marijuana use frequency had concurrent positive associations with depressive symptoms from adolescence to young adulthood, and these associations were significantly stronger for females compared to males. CONCLUSIONS: The results not only support the Self-Medication Model for marijuana use but also provide modest support for the Stress Model, that substance use is associated with depressive symptoms, especially for females.
Authors: Kerry M Green; Katarzyna A Zebrak; Judith A Robertson; Kate E Fothergill; Margaret E Ensminger Journal: Drug Alcohol Depend Date: 2011-12-19 Impact factor: 4.492
Authors: R de Graaf; R V Bijl; J Spijker; A T F Beekman; W A M Vollebergh Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2003-01 Impact factor: 4.328
Authors: Laura Kann; Steve Kinchen; Shari L Shanklin; Katherine H Flint; Joseph Kawkins; William A Harris; Richard Lowry; Emily O'Malley Olsen; Tim McManus; David Chyen; Lisa Whittle; Eboni Taylor; Zewditu Demissie; Nancy Brener; Jemekia Thornton; John Moore; Stephanie Zaza Journal: MMWR Suppl Date: 2014-06-13
Authors: Krista M Lisdahl; Susan Tapert; Kenneth J Sher; Raul Gonzalez; Sara Jo Nixon; Sarah W Feldstein Ewing; Kevin P Conway; Alex Wallace; Ryan Sullivan; Kelah Hatcher; Christine Kaiver; Wes Thompson; Chase Reuter; Hauke Bartsch; Natasha E Wade; Joanna Jacobus; M D Albaugh; N Allgaier; A P Anokhin; K Bagot; F C Baker; M T Banich; D M Barch; A Baskin-Sommers; F J Breslin; S A Brown; V Calhoun; B J Casey; B Chaarani; L Chang; D B Clark; C Cloak; R T Constable; L B Cottler; R K Dagher; M Dapretto; A Dick; E K Do; N U F Dosenbach; G J Dowling; D A Fair; P Florsheim; J J Foxe; E G Freedman; N P Friedman; H P Garavan; D G Gee; M D Glantz; P Glaser; M R Gonzalez; K M Gray; S Grant; F Haist; S Hawes; S G Heeringa; R Hermosillo; M M Herting; J M Hettema; J K Hewitt; C Heyser; E A Hoffman; K D Howlett; R S Huber; M A Huestis; L W Hyde; W G Iacono; A Isaiah; M Y Ivanova; R S James; T L Jernigan; N R Karcher; J M Kuperman; A R Laird; C L Larson; K H LeBlanc; M F Lopez; M Luciana; B Luna; H H Maes; A T Marshall; M J Mason; E McGlade; A S Morris; C Mulford; B J Nagel; G Neigh; C E Palmer; M P Paulus; D Pecheva; D Prouty; A Potter; L I Puttler; N Rajapakse; J M Ross; M Sanchez; C Schirda; J Schulenberg; C Sheth; P D Shilling; E R Sowell; N Speer; L Squeglia; C Sripada; J Steinberg; M T Sutherland; R Tomko; K Uban; S Vrieze; S R B Weiss; D Wing; D A Yurgelun-Todd; R A Zucker; Mary M Heitzeg Journal: Drug Alcohol Depend Date: 2021-07-29 Impact factor: 4.852
Authors: Danielle S Kroll; Dana E Feldman; Szu-Yung Ariel Wang; Rui Zhang; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang Journal: J Neurol Sci Date: 2020-08-19 Impact factor: 3.181
Authors: Manuel Herrero-Montes; Cristina Alonso-Blanco; María Paz-Zulueta; Amada Pellico-López; Laura Ruiz-Azcona; Carmen Sarabia-Cobo; Víctor Fradejas-Sastre; Ester Boixadera-Planas; Paula Parás-Bravo Journal: J Clin Med Date: 2021-12-23 Impact factor: 4.241